NCCN Guidelines
Multiple Myeloma
Guidelines
-
NCCN Guidelines Version 7.2021
- Active (symptomatic) Myeloma
- Multiple Myeloma
- Smoldering (asymptomatic) Myeloma
- Solitary Plasmacytoma
Educational Events and Programs
Continuing Education
-
Evolving Concepts in the Diagnosis and Staging of Multiple Myeloma
-
Bonanza of New Treatment Regimens for Multiple Myeloma: What is Right for My Patient?
-
Smoldering Multiple Myeloma: What is the Threshold to Start Treatment?
-
NCCN Pharmacy Updates: Novel Agents for the Treatment of Relapsed/Refractory Multiple Myeloma
International
Translations
-
Chinese Version 2.2021
-
French Version 4.2018
-
German Version 3.2017
-
Italian Version 4.2018
-
Japanese Version 2.2014
-
Korean Version 4.2018
-
Portuguese Version 2.2021
-
Spanish Version 3.2021
Adaptations
-
Portuguese (Latin America) Version 3.2017
-
Spanish (Latin America) Version 2.2014
Harmonized
-
English (Caribbean) Version 4.2018
-
English (Africa) Version 4.2021